Related Experiment Videos
T regulatory cells in allergen-specific immunotherapy
Johan Verhagen1, Alison Taylor, Kurt Blaser
1Swiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.
International Reviews of Immunology
|December 2, 2005
Summary
Allergen-specific immunotherapy (SIT) offers a lasting solution for allergies and asthma by modifying the immune response, unlike medications that only manage symptoms. This review explores SIT mechanisms, focusing on regulatory T cells.
Area of Science:
- Immunology
- Allergy Research
- Respiratory Medicine
Background:
- Rising prevalence of allergic diseases and asthma globally.
- Limitations of pharmacological treatments for allergies, requiring lifelong medication.
- Need for curative treatments addressing the underlying immune response.
Purpose of the Study:
- To review the mechanisms of allergen-specific immunotherapy (SIT).
- To highlight the role of regulatory T cells in SIT.
- To discuss current concepts and recent findings in SIT.
Main Methods:
- Literature review of recent findings on allergen-specific immunotherapy.
- Analysis of current concepts regarding immune system changes induced by SIT.
- Focus on the immunological role of regulatory T cells.
Main Results:
- Allergen-specific immunotherapy (SIT) induces long-lasting changes in the immune response.
- SIT allows for potential cessation of therapy after several years.
- Regulatory T cells play a crucial role in the efficacy of SIT.
Conclusions:
- Allergen-specific immunotherapy provides a potentially curative approach to allergic disorders.
- Understanding SIT mechanisms, particularly the involvement of regulatory T cells, is key.
- Further research into SIT can lead to improved long-term management of allergies and asthma.